RPG Life Sciences Limited Share Price

Equities

RPGLIFE

INE105J01010

Pharmaceuticals

Delayed NSE India S.E. 10:52:18 29/04/2024 BST 5-day change 1st Jan Change
1,560 INR -0.44% Intraday chart for RPG Life Sciences Limited +2.65% +16.81%

Financials

Sales 2022 4.4B 52.74M 4.21B Sales 2023 5.13B 61.45M 4.91B Capitalization 11.58B 139M 11.09B
Net income 2022 515M 6.17M 493M Net income 2023 676M 8.1M 647M EV / Sales 2022 1.98 x
Net cash position 2022 560M 6.71M 536M Net cash position 2023 832M 9.97M 797M EV / Sales 2023 2.1 x
P/E ratio 2022
18 x
P/E ratio 2023
17.1 x
Employees 1,214
Yield 2022
1.71%
Yield 2023
1.71%
Free-Float 29.34%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.44%
1 week+2.65%
Current month+2.09%
1 month+1.12%
3 months-3.73%
6 months+12.57%
Current year+16.81%
More quotes
1 week
1 514.85
Extreme 1514.85
1 588.00
1 month
1 462.00
Extreme 1462
1 610.00
Current year
1 319.35
Extreme 1319.35
1 740.00
1 year
748.60
Extreme 748.6
1 740.00
3 years
421.80
Extreme 421.8
1 740.00
5 years
142.95
Extreme 142.95
1 740.00
10 years
65.80
Extreme 65.8
1 740.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 31/12/15
Director of Finance/CFO - 02/08/20
Compliance Officer - 10/11/11
Members of the board TitleAgeSince
Chairman 66 05/02/08
Director/Board Member 83 05/02/08
Director/Board Member 60 05/02/08
More insiders
Date Price Change Volume
29/04/24 1,560 -0.44% 10 003
26/04/24 1,567 +1.20% 22,781
25/04/24 1,549 +0.44% 5,808
24/04/24 1,542 +0.11% 8,907
23/04/24 1,540 +1.32% 7,758

Delayed Quote NSE India S.E., April 29, 2024 at 10:52 am

More quotes
RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RPGLIFE Stock